Tackling vaccine inequity in 2023 : have we made progress?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Expert review of vaccines - 23(2024), 1 vom: 24. Jan., Seite 1-4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Torreele, Els [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Access |
|---|
| Anmerkungen: |
Date Completed 16.12.2023 Date Revised 25.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14760584.2023.2292771 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365696102 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365696102 | ||
| 003 | DE-627 | ||
| 005 | 20240125232004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14760584.2023.2292771 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1270.xml |
| 035 | |a (DE-627)NLM365696102 | ||
| 035 | |a (NLM)38078804 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Torreele, Els |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tackling vaccine inequity in 2023 |b have we made progress? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2023 | ||
| 500 | |a Date Revised 25.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Access | |
| 650 | 4 | |a Epidemic preparedness and response (PPR) | |
| 650 | 4 | |a Pandemic Accord | |
| 650 | 4 | |a Research and development (R&D) | |
| 650 | 4 | |a equity | |
| 650 | 4 | |a local manufacturing | |
| 650 | 4 | |a medical Innovation | |
| 650 | 4 | |a pandemics | |
| 650 | 4 | |a resilience | |
| 650 | 4 | |a technology | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of vaccines |d 2002 |g 23(2024), 1 vom: 24. Jan., Seite 1-4 |w (DE-627)NLM126545200 |x 1744-8395 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2024 |g number:1 |g day:24 |g month:01 |g pages:1-4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2023.2292771 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2024 |e 1 |b 24 |c 01 |h 1-4 | ||